Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate whether therapy with MORAb-004 is effective and safe in the treatment of metastatic, colorectal cancer.

Phase 2

Morphotek